Departments of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States.
Division of Pulmonary/Critical Care Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.
Front Immunol. 2022 Aug 15;13:901349. doi: 10.3389/fimmu.2022.901349. eCollection 2022.
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease without effective curative therapy. Recent evidence shows increased circulating myeloid-derived suppressor cells (MDSCs) in cancer, inflammation, and fibrosis, with some of these cells expressing B7H3. We sought to investigate the role of MDSCs in IPF and its potential mediation B7H3. Here we prospectively collected peripheral blood samples from IPF patients to analyze for circulating MDSCs and B7H3 expression to assess their clinical significance and potential impact on co-cultured lung fibroblasts and T-cell activation. In parallel, we assess MDSC recruitment and potential B7H3 dependence in a mouse model of pulmonary fibrosis. Expansion of MDSCs in IPF patients correlated with disease severity. Co-culture of soluble B7H3 (sB7H3)-treated mouse monocytic MDSCs (M-MDSCs), but not granulocytic MDSCs (G-MDSCs), activated lung fibroblasts and myofibroblast differentiation. Additionally, sB7H3 significantly enhanced MDSC suppression of T-cell proliferation. Activated M-MDSCs displayed elevated TGFβ and Arg1 expression relative to that in G-MDSCs. Treatment with anti-B7H3 antibodies inhibited bone marrow-derived MDSC recruitment into the bleomycin-injured lung, accompanied by reduced expression of inflammation and fibrosis markers. Selective telomerase reverse transcriptase (TERT) deficiency in myeloid cells also diminished MDSC recruitment associated with the reduced plasma level of sB7H3, lung recruitment of c-Kit hematopoietic progenitors, myofibroblast differentiation, and fibrosis. Lung single-cell RNA sequencing (scRNA-seq) revealed fibroblasts as a predominant potential source of sB7H3, and indeed the conditioned medium from activated mouse lung fibroblasts had a chemotactic effect on bone marrow (BM)-MDSC, which was abolished by B7H3 blocking antibody. Thus, in addition to their immunosuppressive activity, TERT and B7H3-dependent MDSC expansion/recruitment from BM could play a paracrine role to activate myofibroblast differentiation during pulmonary fibrosis with potential significance for disease progression mediated by sB7H3.
特发性肺纤维化(IPF)是一种进行性肺纤维化疾病,目前尚无有效的治疗方法。最近的证据表明,在癌症、炎症和纤维化中,循环髓系来源的抑制细胞(MDSCs)增加,其中一些细胞表达 B7H3。我们试图研究 MDSCs 在 IPF 中的作用及其对 B7H3 的潜在介导作用。在这里,我们前瞻性地收集了 IPF 患者的外周血样本,以分析循环 MDSCs 和 B7H3 的表达,以评估其临床意义及其对共培养肺成纤维细胞和 T 细胞激活的潜在影响。同时,我们评估了在肺纤维化小鼠模型中 MDSC 的募集和潜在的 B7H3 依赖性。IPF 患者 MDSC 的扩增与疾病严重程度相关。与粒细胞 MDSC(G-MDSC)相比,可溶性 B7H3(sB7H3)处理的小鼠单核细胞 MDSC(M-MDSC)共培养可激活肺成纤维细胞并促进肌成纤维细胞分化。此外,sB7H3 显著增强了 MDSC 对 T 细胞增殖的抑制作用。与 G-MDSC 相比,激活的 M-MDSC 显示出更高的 TGFβ 和 Arg1 表达。用抗 B7H3 抗体治疗可抑制骨髓源性 MDSC 募集到博来霉素损伤的肺中,并伴有炎症和纤维化标志物表达降低。髓细胞选择性端粒酶逆转录酶(TERT)缺陷也减少了 MDSC 的募集,与 sB7H3 血浆水平降低、c-Kit 造血祖细胞肺募集、肌成纤维细胞分化和纤维化减少相关。肺单细胞 RNA 测序(scRNA-seq)显示成纤维细胞是 sB7H3 的主要潜在来源,事实上,激活的小鼠肺成纤维细胞的条件培养基对骨髓(BM)-MDSC 具有趋化作用,这种作用被 B7H3 阻断抗体所阻断。因此,除了其免疫抑制活性外,TERT 和 B7H3 依赖性 MDSC 从 BM 扩增/募集可能发挥旁分泌作用,在肺纤维化期间激活肌成纤维细胞分化,并通过 sB7H3 介导疾病进展具有潜在意义。